OsteoCentric Technologies Secures $30 Million in Growth Capital

By Julie A. Vetalice

OsteoCentric Technologies Secures $30 Million in Growth Capital

OsteoCentric Technologies secured $30 million led by Squadron Capital and OnPoint Advisors. The growth capital will fuel OsteoCentric Trauma's new product introductions which address implant instability and expand applications of UnifiMI™ across spine, joint reconstruction, sports, extremities, veterinary, limb salvage and dental implants.

With UnifiMI, OsteoCentric Technologies is pioneering Mechanical Integration – a less invasive method to instantly secure an implant to bone utilizing a proprietary interlocking thread geometry.

"Orthopedic manufacturers have developed amazing implants over the years, but their methods for securing the implants to bone have remained largely unchanged for decades. Current methods can damage the bone, delay the patient's return to motion, and are not designed to instantly interlock with the bone to optimize implant stability. OsteoCentric invented a less invasive method of securing implants to bone which is designed to preserve the bone and facilitate the patient's return to motion. Our proprietary thread geometry is capable of instantly interlocking with the bone to optimize acute and long-term implant stability. Based on the widespread adoption of UnifiMI products by key opinion leader surgeons, mechanically integrated implants are rapidly setting a new performance standard for instantly securing implants to normal and compromised bone," stated Eric W. Brown, Founder and CEO of OsteoCentric.

Source: OsteoCentric Technologies

Tags: Funding